Cyclacel Pharmaceuticals Inc (CYCCP)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -53.982 | -65.021 | -32.685 | -45.72 | -47.672 | -48.087 | -61.063 | -125.357 |
| Return on Equity (%) | -72.436 | -82.389 | -40.44 | -59.557 | -55.258 | -54.133 | -81.1 | -282.403 |
| Return on Invested Capital (%) | -73.262 | -47.185 | -44.414 | -62.084 | -41.806 | -55.338 | -86.731 | -273.873 |
| Operating Margin (%) | -1633.926 | N/A | -5750 | N/A | N/A | N/A | N/A | -6083.571 |
| Net Profit Margin (%) | -1422.42 | N/A | -4992.667 | N/A | N/A | N/A | N/A | -5418.095 |
| Book Value Per Share | 3.108 | 1.765 | 1.19 | 0.912 | 5.053 | 3.527 | 1.526 | 0.045 |
| Earnings Per Share | -2.611 | -1.204 | -0.584 | -0.626 | -1.887 | -1.807 | -1.632 | -1.679 |
| Cash Per Share | 3.598 | 1.939 | 1.364 | 0.058 | 4.266 | 3.46 | 1.399 | 0.249 |
| Working Capital Per Share | 3.127 | 1.773 | 1.195 | 0.904 | 5.011 | 3.374 | 1.298 | -0.053 |
| Operating Profit Per Share | 0.184 | N/A | 0.012 | N/A | N/A | N/A | N/A | 0.031 |
| EBIT Per Share | -3 | -0.686 | -0.672 | -0.711 | -1.471 | -2.152 | -1.976 | -1.886 |
| EBITDA Per Share | -3 | -0.686 | -0.672 | -0.711 | -1.471 | -2.152 | -1.976 | -1.886 |
| Free Cash Flow Per Share | -2.632 | -1.205 | -0.583 | -0.627 | -1.876 | -1.808 | -1.634 | -1.681 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 4.26M | 12M | 12.5M | 12.5M | 6.25M | 9.99M | 12.54M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | N/A | 12.54M | 12.54M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -14827.586 |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -10158.621 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 17.77M |
| Price to Earnings Ratio | -0.1 |
| Price to Sales Ratio | 5.5 |
| Price to Cash Ratio | 0.68 |
| Price to Book Ratio | 3.81 |
| Dividend Yield | - |
| Shares Outstanding | 1.97M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
